Evidence Brief: Effectiveness of Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder (PTSD)

Evidence Brief: Effectiveness of Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder (PTSD)

Subscribe to the
ESP Report RSS feed

Evidence Brief: Effectiveness of Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder (PTSD)

Investigators: Kim Peterson, MS; Donald Bourne, BS; Johanna Anderson, MPH; Katherine Mackey, MD; Mark Helfand, MD, MS, MPH

Evidence-based Synthesis Program (ESP) Center, Portland VA Health Care System, Portland, OR

Washington (DC): Department of Veterans Affairs; February 2017.

Download PDF: Brief, Supplemental Materials

Purpose

The ESP Coordinating Center (ESP CC) is responding to a request from Office of Community Engagement's (OCE) Center for Compassionate Innovation (CCI) for an evidence brief on the effectiveness of stellate ganglion block (SGB) for treatment of posttraumatic stress disorder (PTSD). Findings from this evidence brief will be used to inform Subject Matter Experts' consideration of clinical use and research and program prioritization for SGB for PTSD in VA.

Objectives of this Evidence Review

To determine to what extent SGB provides clinically relevant benefits for patients with PTSD
To determine SGBs potential harms
To identify patients who are most likely to benefit from SGB

VA Health Systems Research